QUALCOMM Incorporated (BCBA:QCOM)

Checkpoint Therapeutics Income Statement

Financials in millions USD. Fiscal year is October - September.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 29, 2025	Sep 29, 2024	Sep 24, 2023	Sep 25, 2022	Sep 26, 2021	Sep 27, 2020
Revenue	43,257	38,962	35,820	44,200	33,566	23,531
Revenue Growth (YoY)	15.82%	8.77%	-18.96%	31.68%	42.65%	-3.06%
Cost of Revenue	19,172	17,060	15,869	18,635	14,262	9,255
Gross Profit	24,085	21,902	19,951	25,565	19,304	14,276
Selling, General & Admin	2,960	2,759	2,483	2,570	2,339	2,074
Research & Development	8,974	8,893	8,818	8,194	7,176	5,975
Other Operating Expenses	25	-3	-	-	-	-
Operating Expenses	11,959	11,649	11,301	10,764	9,515	8,049
Operating Income	12,126	10,253	8,650	14,801	9,789	6,227
Interest Expense	-672	-697	-694	-490	-559	-602
Interest & Investment Income	181	675	313	91	83	156
Earnings From Equity Investments	-	-	-	-	-	-21
Currency Exchange Gain (Loss)	-	-	-	-	-	-25
Other Non Operating Income (Expenses)	769	177	72	-166	97	55
EBT Excluding Unusual Items	12,404	10,408	8,341	14,236	9,410	5,790
Merger & Restructuring Charges	-107	-107	-712	-	-	-
Gain (Loss) on Sale of Investments	-8	110	-36	-297	864	-99
Legal Settlements	-	-75	-	1,059	-	28
Pretax Income	12,289	10,336	7,443	14,998	10,274	5,719
Income Tax Expense	716	226	104	2,012	1,231	521
Earnings From Continuing Operations	11,573	10,110	7,339	12,986	9,043	5,198
Earnings From Discontinued Operations	5	32	-107	-50	-	-
Net Income to Company	11,578	10,142	7,232	12,936	9,043	5,198
Net Income	11,578	10,142	7,232	12,936	9,043	5,198
Net Income to Common	11,578	10,142	7,232	12,936	9,043	5,198
Net Income Growth	32.90%	40.24%	-44.09%	43.05%	73.97%	18.51%
Shares Outstanding (Basic)	1,106	1,116	1,117	1,123	1,131	1,135
Shares Outstanding (Diluted)	1,116	1,130	1,126	1,137	1,149	1,149
Shares Change (YoY)	-1.20%	0.36%	-0.97%	-1.04%	-	-5.82%
EPS (Basic)	10.47	9.09	6.47	11.52	8.00	4.58
EPS (Diluted)	10.38	8.97	6.42	11.37	7.87	4.52
EPS Growth	34.55%	39.59%	-43.47%	44.42%	74.11%	25.91%
Free Cash Flow	11,622	11,161	9,849	6,834	8,648	4,407
Free Cash Flow Per Share	10.41	9.88	8.75	6.01	7.53	3.84
Dividend Per Share	0.850	3.300	3.100	2.860	2.660	2.540
Dividend Growth	-73.85%	6.45%	8.39%	7.52%	4.72%	2.42%
Gross Margin	55.68%	56.21%	55.70%	57.84%	57.51%	60.67%
Operating Margin	28.03%	26.31%	24.15%	33.49%	29.16%	26.46%
Profit Margin	26.77%	26.03%	20.19%	29.27%	26.94%	22.09%
Free Cash Flow Margin	26.87%	28.65%	27.50%	15.46%	25.76%	18.73%
EBITDA	13,796	11,959	10,459	16,563	11,371	7,620
EBITDA Margin	31.89%	30.69%	29.20%	37.47%	33.88%	32.38%
D&A For EBITDA	1,670	1,706	1,809	1,762	1,582	1,393
EBIT	12,126	10,253	8,650	14,801	9,789	6,227
EBIT Margin	28.03%	26.31%	24.15%	33.49%	29.16%	26.46%
Effective Tax Rate	5.83%	2.19%	1.40%	13.41%	11.98%	9.11%
Revenue as Reported	43,257	38,962	35,820	44,200	33,566	23,531

Source: S&P Global Market Intelligence. Standard template. Financial Sources.